Clinical Trial Update: Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether dexmedetomidine can reduce intraoperative anesthetic requirements in patients undergoing external dacryocystorhinostom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolacrimal Duct Obstruction

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Research Institute of Ophthalmology, Egypt | Conditions: Patients Undergoing External Dacrocystorhinostomy Operations, Assess Decreased Anesthetic Requirements Intraoperative | Phase 1 | Status: RECRUITING